StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$35.57+0.65 (+1.86%)

Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%

Phibro Animal Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Phibro Animal Health's operating income for the twelve months ending Jun 30, 2026 was $194.40M, up 76.0% year over year. For fiscal 2026 it was $194.40M, up 76.0% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $194.40M in fiscal 2026.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026$194.40M+76.0%
FY2025Jun 30, 2025$110.47M+107.2%
FY2024Jun 30, 2024$53.32M-25.8%
FY2023Jun 30, 2023$71.85M-9.0%
FY2022Jun 30, 2022$78.99M+5.5%
FY2021Jun 30, 2021$74.87M+8.2%
FY2020Jun 30, 2020$69.19M-16.9%
FY2019Jun 30, 2019$83.23M-15.9%
FY2018Jun 30, 2018$98.93M+1.0%
FY2017Jun 30, 2017$97.93M+14.2%
FY2016Jun 30, 2016$85.74M-2.2%
FY2015Jun 30, 2015$87.67M+37.4%
FY2014Jun 30, 2014$63.79M+12.4%
FY2013Jun 30, 2013$56.73M+15.0%
FY2012Jun 30, 2012$49.33M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$48.16M+42.8%
Q3 FY2026CQ1 2026Mar 31, 2026$44.65M+33.2%
Q2 FY2026CQ4 2025Dec 31, 2025$50.33M+97.1%
Q1 FY2026CQ3 2025Sep 30, 2025$51.26M+189.6%
Q4 FY2025CQ2 2025Jun 30, 2025$33.72M+83.1%
Q3 FY2025CQ1 2025Mar 31, 2025$33.52M+68.2%
Q2 FY2025CQ4 2024Dec 31, 2024$25.53M+62.6%
Q1 FY2025CQ3 2024Sep 30, 2024$17.70M–
Q4 FY2024CQ2 2024Jun 30, 2024$18.42M-22.5%
Q3 FY2024CQ1 2024Mar 31, 2024$19.92M+7.4%
Q2 FY2024CQ4 2023Dec 31, 2023$15.70M-0.9%
Q1 FY2024CQ3 2023Sep 30, 2023-$726.00K-105.3%
Q4 FY2023CQ2 2023Jun 30, 2023$23.77M+3.8%
Q3 FY2023CQ1 2023Mar 31, 2023$18.55M-3.3%
Q2 FY2023CQ4 2022Dec 31, 2022$15.84M-28.9%
Q1 FY2023CQ3 2022Sep 30, 2022$13.68M-6.4%
Q4 FY2022CQ2 2022Jun 30, 2022$22.89M+19.5%
Q3 FY2022CQ1 2022Mar 31, 2022$19.19M-4.7%
Q2 FY2022CQ4 2021Dec 31, 2021$22.29M+12.1%
Q1 FY2022CQ3 2021Sep 30, 2021$14.61M-6.9%
Q4 FY2021CQ2 2021Jun 30, 2021$19.16M+5.7%
Q3 FY2021CQ1 2021Mar 31, 2021$20.13M-5.6%
Q2 FY2021CQ4 2020Dec 31, 2020$19.89M+1.4%
Q1 FY2021CQ3 2020Sep 30, 2020$15.69M+54.6%
Q4 FY2020CQ2 2020Jun 30, 2020$18.12M+49.8%
Q3 FY2020CQ1 2020Mar 31, 2020$21.32M-5.5%
Q2 FY2020CQ4 2019Dec 31, 2019$19.61M-23.7%
Q1 FY2020CQ3 2019Sep 30, 2019$10.15M-55.6%
Q4 FY2019CQ2 2019Jun 30, 2019$12.10M-53.7%
Q3 FY2019CQ1 2019Mar 31, 2019$22.57M-14.8%
Q2 FY2019CQ4 2018Dec 31, 2018$25.71M+7.4%
Q1 FY2019CQ3 2018Sep 30, 2018$22.85M+2.1%
Q4 FY2018CQ2 2018Jun 30, 2018$26.11M+11.0%
Q3 FY2018CQ1 2018Mar 31, 2018$26.49M-11.6%
Q2 FY2018CQ4 2017Dec 31, 2017$23.94M+5.8%
Q1 FY2018CQ3 2017Sep 30, 2017$22.39M+2.6%
Q4 FY2017CQ2 2017Jun 30, 2017$23.52M–
Q3 FY2017CQ1 2017Mar 31, 2017$29.97M–
Q2 FY2017CQ4 2016Dec 31, 2016$22.63M–
Q1 FY2017CQ3 2016Sep 30, 2016$21.81M–

More Phibro Animal Health figures

See a number that looks wrong?